Bioventus Inc - Ordinary Shares - Class A
NASDAQ:BVS 3:59:50 PM EDT
Other Pre-Announcement
Bioventus Q1 Sales Rose 43.4 Percent To $117.3 Mln
Published: 05/10/2022 11:44 GMT
Bioventus Inc - Ordinary Shares - Class A (BVS) - Bioventus Reports First Quarter Results; Reaffirms Full-year 2022 Financial Guidance.
Q1 Sales Rose 43.4 Percent to $117.3 Million.
Q1 Revenue View $117.7 Million -- Refinitiv Ibes Data (analyst estimates).
Reaffirms Full Year 2022 Financial Guidance.
Q1 Sales Rose 43.4 Percent to $117.3 Million.
Q1 Revenue View $117.7 Million -- Refinitiv Ibes Data (analyst estimates).
Reaffirms Full Year 2022 Financial Guidance.